• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有序列可控主链的瓶刷状聚合物用于增强寡核苷酸递送

Bottlebrush Polymers with Sequence-Controlled Backbones for Enhanced Oligonucleotide Delivery.

作者信息

Wei Yun, Chen Peiru, Ren Mengqi, Li Deng, Lin Jiachen, Sun Tingyu, Wang Yuyan, Yang Shaobo, Nenopoulos Christopher, Oetheimer Christopher, Li Yao, Xue Chenyang, Minkara Mona, Zhang Ke

机构信息

Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts 02115, United States.

Department of Bioengineering, Northeastern University, Boston, Massachusetts 02115, United States.

出版信息

J Am Chem Soc. 2024 Dec 18;146(50):34763-34770. doi: 10.1021/jacs.4c13285. Epub 2024 Nov 27.

DOI:10.1021/jacs.4c13285
PMID:39601327
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11664575/
Abstract

The clinical translation of oligonucleotide-based therapeutics continues to encounter challenges in delivery. In this study, we introduce a novel class of delivery vehicles for oligonucleotides that are based on poly(ethylene glycol) (PEG) bottlebrush polymers with sequence-defined backbones. Using solid-phase synthesis and bespoke phosphoramidites, the oligonucleotide and the polymer backbone can be assembled on the solid support. The synthesis allows chemical modifiers such as carbon 18 (C) units to be incorporated into the backbone in specific patterns to modulate the cell-material interactions. Subsequently, PEG side chains were grafted onto the polymer segment of the resulting polymer-oligonucleotide conjugate, yielding bottlebrush polymers. We report an optimal pattern of the C modifier that leads to improved cellular uptake, plasma pharmacokinetics, biodistribution, and antisense activity . Our results provide valuable insights into the structure-property relationship of polymer-oligonucleotide conjugates and suggest the possibility of tuning the polymer backbone to meet the specific delivery requirements of various diseases.

摘要

基于寡核苷酸的治疗药物的临床转化在递送方面仍面临挑战。在本研究中,我们引入了一类新型的寡核苷酸递送载体,其基于具有序列定义主链的聚乙二醇(PEG)刷状聚合物。使用固相合成和定制亚磷酰胺,可以在固体支持物上组装寡核苷酸和聚合物主链。该合成允许将化学修饰剂(如碳18(C)单元)以特定模式掺入主链中,以调节细胞与材料的相互作用。随后,将PEG侧链接枝到所得聚合物-寡核苷酸缀合物的聚合物链段上,得到刷状聚合物。我们报告了一种C修饰剂的最佳模式,该模式可导致细胞摄取、血浆药代动力学、生物分布和反义活性得到改善。我们的结果为聚合物-寡核苷酸缀合物的结构-性质关系提供了有价值的见解,并表明了调整聚合物主链以满足各种疾病特定递送要求的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/004b/11664575/5e5972d3f3f6/ja4c13285_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/004b/11664575/315d50fff507/ja4c13285_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/004b/11664575/6df89563c1aa/ja4c13285_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/004b/11664575/fc950d7c3657/ja4c13285_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/004b/11664575/17d9d53e206f/ja4c13285_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/004b/11664575/5e5972d3f3f6/ja4c13285_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/004b/11664575/315d50fff507/ja4c13285_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/004b/11664575/6df89563c1aa/ja4c13285_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/004b/11664575/fc950d7c3657/ja4c13285_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/004b/11664575/17d9d53e206f/ja4c13285_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/004b/11664575/5e5972d3f3f6/ja4c13285_0005.jpg

相似文献

1
Bottlebrush Polymers with Sequence-Controlled Backbones for Enhanced Oligonucleotide Delivery.具有序列可控主链的瓶刷状聚合物用于增强寡核苷酸递送
J Am Chem Soc. 2024 Dec 18;146(50):34763-34770. doi: 10.1021/jacs.4c13285. Epub 2024 Nov 27.
2
Improving the Enzymatic Stability and the Pharmacokinetics of Oligonucleotides via DNA-Backboned Bottlebrush Polymers.通过 DNA 骨干刷状聚合物提高寡核苷酸的酶稳定性和药代动力学特性。
Nano Lett. 2018 Nov 14;18(11):7378-7382. doi: 10.1021/acs.nanolett.8b03662. Epub 2018 Nov 2.
3
Bottlebrush Polyethylene Glycol Nanocarriers Translocate across Human Airway Epithelium via Molecular Architecture-Enhanced Endocytosis.瓶刷状聚乙二醇纳米载体通过分子架构增强的内吞作用跨人呼吸道上皮细胞转运。
ACS Nano. 2024 Jul 9;18(27):17586-17599. doi: 10.1021/acsnano.4c01983. Epub 2024 Jun 27.
4
Degradable Bottlebrush Polypeptides and the Impact of their Architecture on Cell Uptake, Pharmacokinetics, and Biodistribution In Vivo.可降解瓶刷多肽及其结构对细胞摄取、药代动力学和体内生物分布的影响。
Small. 2023 Jun;19(22):e2300767. doi: 10.1002/smll.202300767. Epub 2023 Feb 26.
5
PEG-Detachable Polymeric Micelles Self-Assembled from Amphiphilic Copolymers for Tumor-Acidity-Triggered Drug Delivery and Controlled Release.聚乙二醇修饰的两亲性嵌段共聚物聚合物胶束用于肿瘤酸性触发的药物递送和控制释放
ACS Appl Mater Interfaces. 2019 Feb 13;11(6):5701-5713. doi: 10.1021/acsami.8b13059. Epub 2019 Jan 29.
6
A Long-Circulating Vector for Aptamers Based upon Polyphosphodiester-Backboned Molecular Brushes.基于聚磷酸二酯骨架分子刷的适体长循环载体。
Angew Chem Int Ed Engl. 2022 Oct 10;61(41):e202204576. doi: 10.1002/anie.202204576. Epub 2022 Sep 6.
7
Modifying the Backbone Chemistry of PEG-Based Bottlebrush Block Copolymers for the Formation of Long-Circulating Nanoparticles.修饰基于 PEG 的瓶刷嵌段共聚物的骨架化学,以形成长循环纳米粒子。
Adv Healthc Mater. 2024 Sep;13(22):e2304040. doi: 10.1002/adhm.202304040. Epub 2024 May 22.
8
Self-Assembled DNA-PEG Bottlebrushes Enhance Antisense Activity and Pharmacokinetics of Oligonucleotides.自组装 DNA-PEG 瓶刷增强寡核苷酸的反义活性和药代动力学。
ACS Appl Mater Interfaces. 2020 Oct 14;12(41):45830-45837. doi: 10.1021/acsami.0c13995. Epub 2020 Sep 30.
9
Delivery of antisense oligonucleotides using poly(alkylene oxide)-poly(propylacrylic acid) graft copolymers in conjunction with cationic liposomes.使用聚环氧烷-聚丙烯酸丙酯接枝共聚物结合阳离子脂质体递送反义寡核苷酸。
J Control Release. 2014 Nov 28;194:103-12. doi: 10.1016/j.jconrel.2014.08.023. Epub 2014 Sep 1.
10
Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.聚合物结构对聚乙二醇化纳米颗粒的表面性质、血浆蛋白吸附及细胞相互作用的影响。
J Biomed Mater Res A. 2008 Dec 15;87(4):885-95. doi: 10.1002/jbm.a.31800.

引用本文的文献

1
Enhancing the Pharmacokinetics of Aptamers: Targeting AXL In Vivo Using a Bottlebrush Polymer-Conjugated Aptamer.增强适体的药代动力学:使用刷状聚合物偶联适体在体内靶向AXL
Adv Healthc Mater. 2025 Jun 26:e2405083. doi: 10.1002/adhm.202405083.

本文引用的文献

1
Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders.反义寡核苷酸疗法治疗单基因疾病的可能性与局限性。
Commun Med (Lond). 2024 Jan 5;4(1):6. doi: 10.1038/s43856-023-00419-1.
2
Enabling safer, more potent oligonucleotide therapeutics with bottlebrush polymer conjugates.用瓶刷聚合物缀合物实现更安全、更有效的寡核苷酸治疗。
J Control Release. 2024 Feb;366:44-51. doi: 10.1016/j.jconrel.2023.12.035. Epub 2023 Dec 29.
3
Antisense oligonucleotide therapy for H3.3K27M diffuse midline glioma.
反义寡核苷酸治疗 H3.3K27M 弥漫性中线胶质瘤。
Sci Transl Med. 2023 Apr 12;15(691):eadd8280. doi: 10.1126/scitranslmed.add8280.
4
Utilizing endosomal capture for tumor therapy via membrane-lytic mechanism-based Pickering emulsion.通过基于膜裂解机制的皮克林乳液利用内体捕获进行肿瘤治疗。
J Control Release. 2023 Feb;354:523-537. doi: 10.1016/j.jconrel.2023.01.035. Epub 2023 Jan 19.
5
A Long-Circulating Vector for Aptamers Based upon Polyphosphodiester-Backboned Molecular Brushes.基于聚磷酸二酯骨架分子刷的适体长循环载体。
Angew Chem Int Ed Engl. 2022 Oct 10;61(41):e202204576. doi: 10.1002/anie.202204576. Epub 2022 Sep 6.
6
Targeting oncogenic KRAS with molecular brush-conjugated antisense oligonucleotides.用分子刷偶联反义寡核苷酸靶向致癌 KRAS。
Proc Natl Acad Sci U S A. 2022 Jul 19;119(29):e2113180119. doi: 10.1073/pnas.2113180119. Epub 2022 Jul 14.
7
Oligonucleotide Therapeutics: From Discovery and Development to Patentability.寡核苷酸疗法:从发现、开发到可专利性
Pharmaceutics. 2022 Jan 22;14(2):260. doi: 10.3390/pharmaceutics14020260.
8
Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles.寡核苷酸治疗药物的递送:化学修饰、脂质纳米粒和细胞外囊泡。
ACS Nano. 2021 Sep 28;15(9):13993-14021. doi: 10.1021/acsnano.1c05099. Epub 2021 Sep 10.
9
Delivery of oligonucleotide-based therapeutics: challenges and opportunities.寡核苷酸类治疗药物的递送:挑战与机遇。
EMBO Mol Med. 2021 Apr 9;13(4):e13243. doi: 10.15252/emmm.202013243. Epub 2021 Apr 6.
10
Advances in oligonucleotide drug delivery.寡核苷酸药物递送的进展。
Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11.